Temam S, Varraso R, Pornet C, Sanchez M, Affret A, Jacquemin B, et al. Ability of ecological deprivation indices to measure social inequalities in a French cohort. BMC Public Health. 2017 Dec 15;17(1):956.
Ghosn W, Menvielle G, Rican S, Rey G. Associations of cause-specific mortality with area level deprivation and travel time to health care in France from 1990 to 2007, a multilevel analysis. BMC Public Health. 2017 Aug 2;18(1):86.
Mercereau L, Todd N, Rey G, Valleron A-J. Comparison of the temperature-mortality relationship in foreign born and native born died in France between 2000 and 2009. Int J Biometeorol. 2017 May 25;
Pouessel G, Claverie C, Labreuche J, Dorkenoo A, Renaudin J-M, Eb M, et al. Fatal anaphylaxis in France: analysis of national anaphylaxis data, 1979-201J Allergy Clin Immunol. 2017 Mar 7;
Ngantcha M, Le-Pogam M-A, Calmus S, Grenier C, Evrard I, Lamarche-Vadel A, et al. Hospital quality measures: are process indicators associated with hospital standardized mortality ratios in French acute care hospitals? BMC Health Serv Res. 2017 Aug 22;17(1):578.
Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 Aug 23;
Avouac J, Amrouche F, Meune C, Rey G, Kahan A, Allanore Y. Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years. Semin Arthritis Rheum. 2017 Apr;46(5):537–43.
Affret A, Severi G, Dow C, Rey G, Delpierre C, Boutron-Ruault M-C, et al. Socio-economic factors associated with a healthy diet: results from the E3N study. Public Health Nutr. 2017 Jun;20(9):1574–83.
Moreno-Betancur M, Sadaoui H, Piffaretti C, Rey G. Survival Analysis with Multiple Causes of Death: Extending the Competing Risks Model. Epidemiology. 2017 Jan;28(1):12–9.
Ecoffey C, Auroy Y, Pequignot F, Jougla E, Clergue F, Laxenaire M-C, et al. A French survey of paediatric airway management use in tonsillectomy and appendicectomy. Paediatr Anaesth. 2003 Sep;13(7):584–8.
Rey G, Jougla E. Are alcohol-attributable mortality estimates reliable? Eur J Public Health. 2014 Feb;24(1):3–4.
Viallon V, Banerjee O, Jougla E, Rey G, Coste J. Empirical comparison study of approximate methods for structure selection in binary graphical models. Biom J. 2014 Mar;56(2):307–31.
Saucedo M, Bouvier-Colle M-H, Chantry AA, Lamarche-Vadel A, Rey G, Deneux-Tharaux C. Pitfalls of national routine death statistics for maternal mortality study. Paediatr Perinat Epidemiol. 2014 Nov;28(6):479–88.
Lefeuvre D, Pavillon G, Aouba A, Lamarche-Vadel A, Fouillet A, Jougla E, et al. Quality comparison of electronic versus paper death certificates in France, 2010. Popul Health Metr. 2014;12(1):3.
Romon I, Rey G, Mandereau-Bruno L, Weill A, Jougla E, Eschwège E, et al. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort. Diabet Med. 2014 Aug;31(8):946–53.
Mertes PM, Alla F, Tréchot P, Auroy Y, Jougla E, Groupe d’Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011 Aug;128(2):366–73.
Zatoński WA, HEM project team. Epidemiological analysis of health situation development in Europe and its causes until 1990. Ann Agric Environ Med. 2011 Dec;18(2):194–202.
Bouillon K, Haddy N, Delaloge S, Garbay J-R, Garsi J-P, Brindel P, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011 Jan 25;57(4):445–52.
Rogel A, Belot A, Suzan F, Bossard N, Boussac M, Arveux P, et al. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri. Cancer Epidemiol. 2011 Jun;35(3):243–9.
Bouvier A-M, Remontet L, Jougla E, Launoy G, Grosclaude P, Buémi A, et al. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877–81.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004 Jul 15;101(2):317–24.